Vena Vitals Inc.
Irvine, CA
- UEI
- EHSLFPGBL8K5
- CAGE
- 8FM54
- Primary NAICS
- 339112 Surgical and Medical Instrument Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 5270 California Ave #300, Irvine, CA 92617, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Kilele Health Inc. | Dayton, OH | — |
| Dynocardia, Inc. | Newton, MA | 334510 Electromedical and Electrotherapeutic Apparatus Manufacturing |
| Pyrames Inc. | Cupertino, CA | 339112 Surgical and Medical Instrument Manufacturing |
| Huxley Medical, Inc. | Atlanta, GA | 334510 Electromedical and Electrotherapeutic Apparatus Manufacturing |
| Aventusoft L.l.c | Boca Raton, FL | 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
About the company
Vena Vitals Inc. is a for-profit corporate entity registered in Irvine, California, specializing in advanced biomedical monitoring technologies with a specific focus on cardiovascular health measurement devices. The company is a women-owned small business that has been actively registered in SAM.gov since October 2019 and concentrates on developing innovative wearable technologies for continuous, non-invasive blood pressure monitoring. Their core technological approach involves creating sophisticated sensor systems that can capture high-resolution physiological data, particularly related to cardiovascular metrics, using micro-nanoscale functional materials.
The company has secured multiple federal grants from prestigious agencies like the National Heart, Lung, and Blood Institute (NHLBI) and the National Science Foundation (NSF), predominantly focused on developing advanced blood pressure monitoring technologies. Their grant-funded projects include developing VeriSleep, a wearable device for continuous cardiovascular biomarker monitoring during sleep, a wearable alert system for detecting postoperative hypotension, and a beat-to-beat blood pressure monitor using specialized wrinkled functional materials. These projects have ranged from Small Business Innovation Research (SBIR) Phase I and Phase II awards to project grants, with funding amounts between $256,000 and $306,872. The research aims to address critical gaps in current medical monitoring technologies, such as providing more comprehensive and continuous blood pressure tracking in surgical, critical care, and sleep disorder contexts, with potential applications in improving patient outcomes and understanding cardiovascular health risks.
Quick answers
Is Vena Vitals Inc. registered in SAM.gov?
Yes. Vena Vitals Inc.'s SAM.gov registration is active through January 2, 2027.
What is Vena Vitals Inc.'s most recent federal award?
Vena Vitals Inc.'s most recent federal grant award is Continuous non-invasive blood pressure during sleep as a cardiovascular biomarker - blood pressure (BP) is one of the… (R43HL180283), from National Heart Lung and Blood Institute (NIH), on September 24, 2025.
On GovTribe
See Vena Vitals Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors